Particulars |
Company Name |
Marksans Pharma Ltd |
Year End |
202303 |
Full Year |
Equity (Rs Cr.) |
45.32 |
B.V. Rs |
25.70 |
Sales Rs Cr. |
655.20 |
NP Rs Cr. |
102.91 |
NP Var% |
-1.00 |
Div% |
50.00 |
CPS Rs |
2.60 |
EPS Rs |
2.30 |
Traded Value(Rs Lakhs) |
152.86 |
52 Week High |
185.00 |
52 Week Low |
70.00 |
Price BSE |
166.00 |
Price NSE |
166.00 |
Market Capital(Rs Cr.) |
7,513.45 |
P/C Ratio |
62.90 |
P/E Ratio |
73.10 |
Price Vs.BV |
6.46 |
|
Latest Quarter |
Year End |
202312 |
Sales Rs Cr. |
241.36 |
NP Rs Cr. |
25.29 |
NP Var % |
-1.00 |
Trailing Twelve Months |
Year End |
202312 |
Sales |
671.63 |
OPM |
14.90 |
NP |
106.92 |
NP Var% |
11.36 |
EPS |
2.62 |
PE |
63.28 |
|
|